Europeptides Part of Tides Europe

Where peptide leaders meet to build successful partnerships and accelerate products across all development phases

Increase half-life and minimise manufacturing costs through new data, case studies and technologies for peptide therapeutics

Lead optimisation strategies to improve drug-like properties for next generation peptide therapeutics
• Peptide therapeutics beyond metabolic diseases - Where are the future opportunities?
• Overcome the challenges of translating early leads into the clinic - Zealand Pharma and Amgen provide successful lead optimisation and engineering insights
• New frontiers in peptide design– What are the latest developments in peptide vaccines, conjugates, macrocyclic and antimicrobial peptides?
• Increasing the half-life, targeting and stability of peptide products – What are the cutting edge methodologies to move to longer exposure times?

New techniques for improved administration of peptide products
• Preclinical and clinical developments of complex peptides – What are the most exciting products advancing through the clinic?
• Benchmark your clinical programmes with case studies insights from Bicycle Therapeutics and Polyphor
• Non-invasive delivery methods - What are the latest advances in orally bioavailable, transdermal and controlled release peptides?
• Formulation strategies – Which are the winning techniques and technologies for sustained release?

Latest developments in large scale peptide manufacturing to reduce cost of goods
• Optimising process development, CMC and large scale manufacturing - How are industry overcoming the challenges of peptide scale up and production?
• Solid phase synthesis – Which new coupling methods and linkers can improve manufacturing efficiency?

Price : 2 Day Conference Pass (Days 2 & 3): GBP 1349